Bank Of America Corp Trevi Therapeutics, Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 44,284 shares of TRVI stock, worth $124,880. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,284
Previous 21,976
101.51%
Holding current value
$124,880
Previous $75,000
74.67%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TRVI
# of Institutions
83Shares Held
56.7MCall Options Held
15.6KPut Options Held
0-
Nea Management Company, LLC Timonium, MD11.4MShares$32.1 Million3.2% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA7.38MShares$20.8 Million1.3% of portfolio
-
Rubric Capital Management LP New York, NY5.03MShares$14.2 Million0.47% of portfolio
-
Viking Global Investors LP4.4MShares$12.4 Million0.05% of portfolio
-
Vr Adviser, LLC New York, NY3.42MShares$9.65 Million1.12% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $164M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...